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Abstract
Objective: The objective of this selective EBM review is to determine whether or not Ayurvedic
is effective in reducing osteoarthritis pain in adults.
Study Design: Review of three English language randomized controlled trials published
between from 2004-2013.
Data Sources: Two double blind randomized controlled trials and one open label randomized
controlled clinical trial were found using PubMed and Cochrane Library databases.
Outcomes Measured: To measure the effectiveness, the following parameters were utilized
visual analog scale (VAS) reported by the patient to assess reduction in pain symptoms of
osteoarthritis.
Results: Three randomized controlled studies results found that Ayurvedic medicine was
beneficial in providing symptomatic pain relief in patients of osteoarthritis in adults.
Conclusions: The results of all three selected studies in this systemic review demonstrated that
Ayurvedic provides some effectiveness in reducing osteoarthritis pain in adults when compared
to conventional medications used for osteoarthritis.
Key Words: Ayurvedic medicine, Ayurveda, and Osteoarthritis
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INTRODUCTION
Osteoarthritis is the most common type of arthritic disease, causing degenerative changes
to the joints from everyday “wear and tear,” causing disability, pain and loss of function.3,4 This
paper evaluates two double blind, randomized controlled clinical trials and an open label
randomized controlled clinical trial comparing the efficacy of Ayurveda. For many centuries, in
Eastern medicine, herbs have been used manage and treat osteoarthritis as an alternative form
using conventional medicine.

Ayurveda is a popular herbomineral drug in the Indian

subcontinent that utilizes a holistic approach for alleviating symptoms of osteoarthritis pain in
adults.1,2
Approximately 27 million people in the United States have osteoarthritis.

It is the

leading cause of disability in non-institutionalized adults.4,5 Both incidence and prevalence of
osteoarthritis are on the rise due to increasing age and obesity.5 Due to the growing populations
that are effected with osteoarthritis it has a become a financial burden on both the healthcare
system and patient population. The estimated average patient’s out of pocket cost is $2,600 per
year.4 Osteoarthritis accounts for 69.9% of all arthritis-related hospitalizations.4
Osteoarthritis develops gradually; however there are unknown parameters of causes,
which contribute to degenerative changes resulting in an overall arthritic disease state of the
joints.5 Osteoarthritis is characterized with following symptoms: pain, swelling, and stiffness,
loss of flexibility, grating sensation, and development of bone spurs noted in radiographic
images.6
The management of osteoarthritis requires a multidisciplinary approarch.3 The use of
acetaminophen, NSAIDs, narcotics, cortisone injections, engaging in physical and occupational
therapy, exercise, proper weight management, and surgical options such as bone realignment and
joint replacements can all help improve symptoms of osteoarthritis.1,2,3 Currently, there is no

KHAN, Ayurvedic & Osteoarthritis 2

cure for osteoarthritis; the above methods are utilized to help alleviate the symptoms of
osteoarthritis.4 Due to its popular use in Eastern medicine and the growing trend for using herbal
remedies, it is believed that Ayurveda may provide an alternative method of relief for
osteoarthritis symptoms.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not Ayurvedic is
effective in reducing osteoarthritis pain in adults.
METHODS
The criteria used for the selections of studies included the population of adult patients with
osteoarthritis diagnoses with radiographic changes and an intervention of Ayurvedic medicine,
with comparisons made with common conventional treatments such as nonsteroidal antiinflammatory drugs (NSAIDs), Celecoxib, and Diclofenac.

The outcomes measured were

reduction and improvement pain symptoms of osteoarthritis. The studies utilized in this systemic
review included three randomized controlled trials, specifically two double blind randomized
controlled clinical trials and one open label randomized controlled clinical trial.
The selections of this systemic review included a literature search using the Cochrane
Library and PubMed databases and were limited search to the following keywords: “Ayurvedic
medicine”, “Ayurveda”, and “osteoarthritis.” All articles were written in English and published
in peer-reviewed journals between the years 2004 and 2013. All articles that were selected for
this systemic review are based on their relevance to the topic and on the patient-oriented
outcomes (POEMs). Inclusion criteria included that the studies selected for this systemic review
were randomized controlled and either double blind or open label, adult patients with
osteoarthritis pain with radiographic changes. Exclusion criteria included those patients less than
18 years of age, pregnant or lactating women.

Table 1 outlines the demographics and
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characteristics of the selected studies used in this systemic review. The statistics reported in the
selected studies were p-values, confidence intervals (CI), ANOVA, and unpaired T-test.

Table 1 - Demographics & Characteristics of included studies
Study
Chopra1
(2004)

Type
Randomized
controlled
trial (doubleblind)

# pts
358

Age Inclusion Criteria
>35 OA of knee
yrs classified via ACR
and radiologic
criteria.
VAS > 40 mm.
Patient on a stable
dose of a NSAID.
Female patients of
child-bearing
potential only if
practicing
contraception.

Chopra2
(2013)

Randomized
controlled
trial (doubleblind)

440

4070
yrs

Pengkhum3
(2012)

Randomized
controlled
trial (open
label)

60

>50
yrs

Diagnosis of knee
OA with the ACR
criteria. VAS score
of 54 cm in one or
both knees.
Ambulant patients
that required
frequent analgesics.

OA diagnosed with
radiographs and
assessed by the
Kellgren et al
grading system.
Patients using

Exclusion Criteria
Pregnant or
lactating women.
Hx uncontrolled
medical disease or
abnormal renal
and hepatic
function.
Received intraarticular
corticosteroid
injections in the
knee joint within
3 months.
Hypersensitivity
to RA-11 or its
components.
Pregnant or
lactating or
women.
Hx of non-DJD,
severe disabling
arthritis or spine
and lower limb
surgery, peptic
ulcer bleed, or
any unstable
severe medical
disease.
Patients on
medication that
may influence
efficacy
evaluation.
Hx of severe RA
inflammatory
arthropathy,
recent knee injury
or received intraarticular

W/D

28

123

Intervention
RA-11
(ARTREX,
MENDAR)
2 capsules BID

Ayurvedic
(SGCG)
400mg, 2
capsules TID
Ayurvedic SGC
400mg, 2
capsules TID

9

Ayurved Siriraj
Wattana Recipe
900 mg/day
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acetaminophen for
the most painful
knee movement
assessed by a VAS
>4.

treatment.
Patients that were
expectation of
future surgery.

OUTCOMES MEASUERED
Outcomes measured in the selected studies were based on patient-oriented outcomes
(POEMs) of reduction in pain symptoms of osteoarthritis, at rest and during weight bearing
activities. These outcomes were measure via the visual analog scale (VAS), the Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC), the Oxford-12, and global
assessment by both the patients and physicians in the selected studies.
Both studies conducted by A. Chropra et al. utilized the visual analog scale, and
WOMAC questionnaire to assess knee and/or hip pain in osteoarthritis patients. VAS assessed
active pain on body weight-bearing activity, such as walking, and at rest of subjects with scores
ranging from 0 for no pain and 10 for maximum pain.
Pengkhum et al. utilized the Oxford-12 questionnaire and the VAS for the assessment of
function and pain of the knee in osteoarthritis patients judged by the patient. The VAS assessed
pain during the most painful knee movement.
RESULTS
In the selected study conducted by Chopra et al. (2004) assessing the RA-11 (Ayurvedic)
compared to a placebo taken twice a day after meals, in the treatment of patients with
osteoarthritis of the knees. The study design was a randomized, double-blind, parallel efficacy
and placebo-controlled trial for the duration of 32 weeks. Overall 90 subjects participated in the
study and were randomly assigned that received the allocated treatments described above, and
there were no significant difference between the groups. The study evaluation was made at
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baseline and every week until completion of 32 weeks. Total of 28 subjects withdrew from trial.
The study was presented in continuous data and intention to treat with the last observation
carried out using analysis of variance (ANOVA). Active pain VAS and WOMAC pain were
used to compare the two groups, with the focus on active pain VAS for RA-11 comparison to the
placebo control demonstrated by Table 2.1 The mean change in efficacy was measured at week
16 displaying the VAS for pain, for RA-11 -2.68 and placebo -1.30, with a p-value of 0.000 and
for week 32, RA-11 -2.83 and placebo -1.80, with a p-value of 0.034, due to a plateau-like effect
as the trial progressed.
Table 2: Mean change in efficacy at week 16 and week 32 (Mean and SD) from Chopra et al.
(2004)
Variable e

VAS for pain

Week 16 Treatment
Active Placebo
P*
-2.68, -1.30, 0.000
(+/(+/0.29)
0.31)

Week 32 Treatment
Active Placebo
P*
-2.83
-1.86, 0.034
(+/(+/0.38)
0.36)

P* analysis of variance.
In the selected study conducted by Chopra et al. (2013) compared two standard
Ayurvedic formulations (SGCG and SGC) to glucosamine (2 g daily) and Celecoxib (200 mg
daily) which were given two capsules three times a day with plain water to assess effectiveness.
SGCS formulation contained an additional plant extract, B. serrata allowing it to be of higher
potency, which was not found in the SGC formulation of the Ayurvedic medicine. The study
design was a randomized double-blind for the duration of 24 weeks. The study evaluation was
made at baseline and weeks 2, 4, 8, 12, 16, 20 and 24. Overall 440 subjects participated in the
study and were randomly assigned into four groups of 110 participants that received the allocated
treatments described above, and there were no significant difference between the groups. Total
of 126 (28.6%) subjects withdrew from trial. The study was presented in continuous data and
intention to treat with the last observation carried out using analysis of variance (ANOVA).
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Active pain VAS and WOMAC pain were used to compare the four groups, with the focus on
active pain VAS for SGCS comparison to Celecoxib. Efficacy calculated that mean change of
active body weight-bearing pain VAS from baseline to completion was fairly small for SGCG is
-2.04 (CI 95% -2.47, -1.61) compared to Celecoxib is -1.82 (CI 95% -2.20, -1.44). The p-value
is calculated at 0.21 indicating not statistically significant between SGCG and Celecoxib, as
demonstrated by Table 3.2
Table 3: Efficacy from baseline to completion intent-to-treat analysis from Chopra et al. (2013)
SGCS (Ayurvedic
medicine)
Active pain VAS
(mean change)

-2.04 (CI 95% -2.47, -1.61)

Celecoxib

P
(comparison,
ANOVA)
-1.82 (CI 95% -2.20, -1.44)
0.21

In the selected study conducted by Pengkhum et al. assessed the use of Ayurved Siriraj
Wattana recipe (900 mg/day) comparing it with Diclofenac (75 mg/day), for providing
symptomatic relief in patients with osteoarthritis of the knee. The study design was randomized,
open-label, NSAIDs controlled trial for the duration of 12 weeks. Overall, there were 60 subjects
participated in the study and were equally divided and randomly assigned to a treatment group. It
was reported that 27 patients (90%) in Ayurved Siriraj Wattana recipe group and 24 patients
(80%) in Diclofenac group completed the study, thus nine patients withdrew from the study. The
study was presented in continuous data and statistical significant was evaluated by using
unpaired T-test. VAS was utilized to assess the reduction in pain when Ayurved Siriraj Wattana
recipe and Diclofenac are used at 2, 4, 8, and 12 weeks, as demonstrated by Table 4. On week
12, efficacy was calculated for VAS assessed pain the mean change for Ayurved Siriraj Wattana
recipe at 4.37 compared to Diclofenac 4.42 as small, with the p-value calculated at 0.94
indicating not statistically significant.3
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Table 4: Efficacy at baseline and follow-up visits from Pengkhum et al. (2012)
VAS assessed pain

Wattana
(mean)
6.63
5.93
5.48
4.89
4.37

Baseline
Week 2
Week 4
Week 8
Week 12

Diclofenac
(mean)
6.58
5.17
5.58
4.25
4.42

95% CI

p-value

-0.899, 0.807
-1.594, 0.075
-0.693, 0.896
-1.568, 0.291
-0.909, 0.973

0.91
0.07
0.79
0.17
0.94

For all three selected studies safety and tolerability of each intervention was measured via
number of adverse events during each trial and recorded. Table 5 shows the overall adverse
effects that result in Number Needed Harm (NNH) for the selected studies.
Table 5: Adverse Effects that result in NNH for the selected studies
Study
Chopra1
(2004)
Chopra2
(2013)
Pengkhum3
(2012)

Ayurvedic
Medicine’s
AE (%)
27.7

Placebo or
Comparison
Drug’s AE (%)
26.5

RRI(%)

ARI(%)

NNH

4.5

1.2

83

28.16

32.38

12.9

4.2

24

6.6

9.9

33.3

3.3

30

DISCUSSUION
Osteoarthritis is chronic condition that causes a wide range of problems in many patient
population, and current conventional medication used have adverse side effects associated with
them.

Therefore, the goal of Ayurvedic medicine is to provide symptomatic relief from

osteoarthritis pain.
Limitations exist in all the selected studies. The limitations of the selected studies are as
follows: various formulations of Ayurvedic medicine were utilized, the studies used different
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dosages, only Asian decent subjects participated in the study, and it is hypothesized that
Ayurevedic medicine is considered safe, because of its long history of use in the Eastern culture
but with limited evidence support. Specifically, Chopra et al. (2004) researchers were unable to
explain the precise reason for the strong placebo response and a large number of patients
withdrew from the study, Chopra et al. (2013) used a large number of participants (440) which
would be harder to assess efficacy and follow-up, and Pengkhum et al. mostly females were
enrolled in the study.1,2,3 Due to these limitations, there is a need for more research to be
conducted to warrant the effectiveness of Ayurvedic medicine in reducing osteoarthritis pain in
adults.
CONCLUSION
This systemic review investigated three studies of randomized control trials that
demonstrated the effectiveness of Ayurvedic medicine used for managing pain in adults patients
with osteoarthritis.

The selected studies for this systemic review demonstrated Ayurvedic

medicine is effective when compared to conventional treatments, such as Celecoxib and
Diclofenac, and is statistical significant when compared to placebo.1,2,3 Ayurvedic medicine has
been used for centuries and provides patients of osteoarthritis an alternative therapeutic option
which can help decrease the side-effects of NSAIDs, such as gastrointestinal ulcers and comorbidities.

Future studies need to be conducted to determine the efficacy of Ayurvedic

medicine in osteoarthritis patients, which are open globally and assess subjects from all origins
to assess if Ayurvedic medicine is effective in reducing osteoarthritis pain in adults.
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